Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
Nick Norwitz interviews Aseem Malhotra, MD, a consultant cardiologist, on controversial new findings challenging LDL cholesterol’s role as an independent risk factor for heart disease. They discuss data…
NEW YORK (Reuters Health) – Among patients with atrial fibrillation on amiodarone, the incidence of thyroid dysfunction is identical in those taking the brand-name formulation of the drug…
NEW YORK (Reuters Health) – Giving elderly patients with acute MI a clopidogrel loading dose of 300 mg or more rather than a lower conventional dose doesn’t increase…
NEW YORK (Reuters Health) – A new population-based study finds the incidence of pulmonary complications associated with amiodarone to be relatively low, but still 50% higher among patients…
NEW YORK (Reuters Health) – In patients with atrial fibrillation (AF), combination antithrombotic therapy with an anticoagulant and an antiplatelet increases the risk for clinically relevant bleeding with…
NEW YORK (Reuters Health) – Patients with an implantable converter-defibrillator (ICD) that uses fracture-prone Fidelis leads have similar survival rates as ICD patients with another type of lead,…
NEW YORK (Reuters Health) – Patients with depression or diabetes have an increased risk of MI, but the risk is even higher in patients with both conditions, according…
NEW YORK (Reuters Health) – African Americans are less likely to develop atrial fibrillation after isolated coronary artery bypass graft (CABG) surgery than European Americans, a new study…
NEW YORK (Reuters Health) – Ambulatory blood pressure monitoring (ABPM) is a better predictor of renal and cardiovascular events than office BP measurement in patients with chronic kidney…
NEW YORK (Reuters Health) – Patients with unprotected left main disease and right coronary artery chronic total occlusion (CTO) undergoing percutaneous coronary intervention (PCI) face an increased risk…
NEW YORK (Reuters Health) – An investigational drug AMR101 containing purified eicosapentaenoic acid and no docosahexaenoic acid reduces very high triglyceride levels by up to 45% compared to…
